Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.075 | 0.7 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |